Tuberculosis Infection Testing Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Tuberculosis is an infectious disease with mycobacteria its primary cause. In general, tuberculosis attacks the lungs or even other parts of the body such as the genitourinary system, lymphatic system, and central nervous system. Tuberculosis affected in the lungs is known as Pulmonary Tuberculosis, while effects in other parts of the body are known as extrapulmonary Tuberculosis. It can be proliferated through the air by cough, sneeze or transmit through air. The significant symptoms of tuberculosis are chronic cough, night sweat, blood-tinged sputum, and fever.

MARKET SCOPE

The "Global Tuberculosis Infection Testing Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Tuberculosis infection testing market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Tuberculosis infection testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•  Based on type, the global Tuberculosis infection testing market is segmented into tuberculin skin test (tst), interferon gamma released assay (igra), others.
  
•  On the basis of end use, the market is segmented into hospitals and clinics, diagnostic laboratories, others.
  

MARKET DYNAMICS

Drivers:

•  Rise in the cigarette consumption.
  
•  Growing awareness regarding tuberculosis.
  
•  Rise in geriatric population.
  
•  Rising cases of HIV.
  
•  Growth in Pharmaceutical Research and Development.
  

Restraints:

•  The multidrug resistant tuberculosis and stringent regulation are the major restraining factor for this market.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Tuberculosis infection testing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Tuberculosis infection testing market in these regions.

IMPACT OF COVID-19 ON TUBERCULOSIS INFECTION TESTING MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the Tuberculosis infection testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Tuberculosis infection testing market are anticipated to lucrative growth opportunities in the future with the rising demand for Tuberculosis infection testing in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Tuberculosis infection testing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

 Danaher

 Becton Dickinson

 Bio-Rad

 Qiagen

 Thermo Fisher Scientific

 Roche

 Oxford Immunotec

 Hologic

 Hain Lifescience

 Genedrive plc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Tuberculosis Infection Testing Report Scope

Report Attribute	Details
Market size in 2023	US$ XX Million
Market Size by 2031	US$ XX Million
Global CAGR (2023 - 2031)	XX%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Type Tuberculin Skin Test Interferon Gamma Released Assay By End Use Hospitals and Clinics Diagnostic Laboratories
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Danaher Becton Dickinson Bio-Rad Qiagen Thermo Fisher Scientific Roche Oxford Immunotec Hologic Hain Lifescience